These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6538818)

  • 1. Comments on "The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs".
    Crampton RS; Kaiser DL
    Circ Res; 1984 Apr; 54(4):474-5. PubMed ID: 6538818
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs.
    Huddleston CB; Lupinetti FM; Laws KH; Collins JC; Clanton JA; Hawiger JJ; Oates JA; Hammon JW
    Circ Res; 1983 May; 52(5):608-13. PubMed ID: 6682723
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a thromboxane synthetase inhibitor in circumflex coronary artery occlusion and reperfusion.
    Huddleston CB; Lupinetti FM; Clanton J; Collins J; Oates JA; Hammon JW
    Curr Surg; 1983; 40(3):211-5. PubMed ID: 6683615
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):87S-95S. PubMed ID: 6681710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Tilton GD; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1983; 96():103-12. PubMed ID: 6687298
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
    Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR
    Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-n-Butylimidazole: a potent and selective inhibitor of 'thromboxane synthetase' [proceedings].
    Blackwell GJ; Flower RJ; Russell-Smith N; Salmon JA; Thorogood PB; Vane JR
    Br J Pharmacol; 1978 Nov; 64(3):435P. PubMed ID: 719285
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
    O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR
    Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
    Eddy LJ; Oei HH; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death.
    Hammon JW; Oates JA
    Circulation; 1986 Feb; 73(2):224-6. PubMed ID: 3510761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical prospects for a thromboxane synthetase inhibitor. A Pfizer Central Research Symposium--26th-27th March, 1982.
    Br J Clin Pharmacol; 1983; 15 Suppl 1():5S-139S. PubMed ID: 6681704
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation.
    Bartele V; Cerletti C; Schiepatti A; di Minno G; de Gaetano G
    Lancet; 1981 May; 1(8228):1057-8. PubMed ID: 6112437
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium.
    Coker SJ; Parratt JR; Ledingham IM; Zeitlin IJ
    J Mol Cell Cardiol; 1982 Aug; 14(8):483-5. PubMed ID: 6890999
    [No Abstract]   [Full Text] [Related]  

  • 18. Dipyridamole: a possible potent inhibitor of thromboxane A2 synthetase in vascular smooth muscle.
    Ally AI; Manku MS; Horrobin DF; Morgan RO; Karmazin M; Karmali RA
    Prostaglandins; 1977 Sep; 14(3):607-9. PubMed ID: 905584
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats.
    Leprán I; Parratt JR; Szekeres L; Wainwright CL
    Br J Pharmacol; 1985 Sep; 86(1):229-34. PubMed ID: 4052725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of thromboxane synthetase inhibitors on platelets from different individuals.
    Lancet; 1982 Nov; 2(8308):1156-7. PubMed ID: 6128469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.